HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

TP53 drives invasion through expression of its Δ133p53β variant

Gilles Gadea 1 Nikola Arsic 2 Kenneth Fernandes 3 Alexandra Diot 4 Sébastien Joruiz 5 Samer Abdallah 1 Valerie Meuray 4 Stéphanie Vinot 1 Christelle Anguille 1 Judit Remenyi 5 Marie Khoury 6 Philip Quinlan 7 Colin Purdie 8 Lee Jordan 9 Frances Fuller-Pace 5 Marion de Toledo 1 Maïlys Cren 10 Alastair Thompson 11 Jean-Christophe Bourdon 4 Pierre Roux 12
1 CRBM - Centre de recherche en Biologie cellulaire de Montpellier
2 IGMM - Institut de Génétique Moléculaire de Montpellier
3 Centre for Oncology and Molecular Medicine
4 Centre of Oncology and Molecular Medicine
5 University of Dundee
6 I2MR - Institut de médecine moléculaire de Rangueil
7 Department of Surgery and Molecular Oncology
8 Department of Pathology [Dundee]
9 Dundee Cancer Center
10 Cellules souches normales et cancéreuses
11 Department of Breast Surgical Oncology [Houston]
12 LIST (CEA) - Laboratoire d'Intégration des Systèmes et des Technologies
Abstract : TP53 is conventionally thought to prevent cancer formation and progression to metastasis, while mutant TP53 has transforming activities. However, in the clinic, TP53 mutation status does not accurately predict cancer progression. Here we report, based on clinical analysis corroborated with experimental data, that the p53 isoform D133p53b promotes cancer cell invasion, regardless of TP53 mutation status. D133p53b increases risk of cancer recurrence and death in breast cancer patients. Furthermore D133p53b is critical to define invasiveness in a panel of breast and colon cell lines, expressing WT or mutant TP53. Endogenous mutant D133p53b depletion prevents invasiveness without affecting mutant full-length p53 protein expression. Mechanistically WT and mutant D133p53b induces EMT. Our findings provide explanations to 2 long-lasting and important clinical conundrums: how WT TP53 can promote cancer cell invasion and reciprocally why mutant TP53 gene does not systematically induce cancer progression.
Document type :
Journal articles
Complete list of metadata

Cited literature [57 references]  Display  Hide  Download
https://hal.univ-reunion.fr/hal-01703040
Contributor : Réunion Univ Connect in order to contact the contributor
Submitted on : Thursday, June 28, 2018 - 11:09:06 AM
Last modification on : Tuesday, May 17, 2022 - 2:20:02 PM
Long-term archiving on: : Thursday, September 27, 2018 - 7:35:10 AM

File

Vignette du document
TP53_drives_invasion_through_e...
Publisher files allowed on an open archive

Licence

Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

UNIV-REUNION | INSERM | LIST | UNIV-MONTPELLIER | BS | UNIV-PARIS-SACLAY | DRT | CNRS | CEA | PAPANGUE | UNIV-TLSE3 | GS-COMPUTER-SCIENCE | GS-ENGINEERING | CRBM

Citation

Gilles Gadea, Nikola Arsic, Kenneth Fernandes, Alexandra Diot, Sébastien Joruiz, et al.. TP53 drives invasion through expression of its Δ133p53β variant. eLife, eLife Sciences Publication, 2016, 5, pp.e14734. ⟨10.7554/eLife.14734⟩. ⟨hal-01703040⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

444

Files downloads

232